Recent advances in chronic obstructive pulmonary disease pathogenesis: from disease mechanisms to precision medicine

Citations Over TimeTop 1% of 2019 papers

Abstract

Chronic obstructive pulmonary disease (COPD) is a devastating lung disease with a high personal and societal burden. Exposure to toxic particles and gases, including cigarette smoke, is the main risk factor for COPD. Together with smoking cessation, current treatment strategies of COPD aim to improve symptoms and prevent exacerbations, but there is no disease-modifying treatment. The biggest drawback of today's COPD treatment regimen is the 'one size fits all' pharmacological intervention, mainly based on disease severity and symptoms and not the individual's disease pathology. To halt the worrying increase in the burden of COPD, disease management needs to be advanced with a focus on personalized treatment. The main pathological feature of COPD includes a chronic and abnormal inflammatory response within the lungs, which results in airway and alveolar changes in the lung as reflected by (small) airways disease and emphysema. Here we discuss recent developments related to the abnormal inflammatory response, ECM and age-related changes, structural changes in the small airways and the role of sex-related differences, which are all relevant to explain the individual differences in the disease pathology of COPD and improve disease endotyping. Furthermore, we will discuss the most recent developments of new treatment strategies using biologicals to target specific pathological features or disease endotypes of COPD. © 2020 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

Related Papers

• → Real-Data Comparison of Data Mining Methods in Early Detection of Chronic Obstructive Pulmonary Disease (COPD) in General Practice(2016)2 cited
• → [Progress in study on animal models of chronic obstructive pulmonary disease].(2017)1 cited
• → The Relation between Prevalence of Chronic Obstructive Pulmonary Disease and Smoking Habit by Occupation of Subjects on Human Dry Dock(2003)1 cited
• Animal Models of Chronic Obstructive Pulmonary Disease in Pharmacological Research(2012)
• → Clinical impact of chronic obstructive pulmonary disease (COPD) verified by the COPD Assessment Test (CAT) can be associated with functional capacity?(2018)